Will Johnson & Johnson MedTech’s new CORE-VA registry finally bridge the real-world evidence gap in ventricular arrhythmia care?
Johnson & Johnson MedTech launches the CORE-VA registry to improve ventricular arrhythmia care with real-world data. Find out what it means for the sector! Read More
Novo Nordisk stock rises on Wegovy STEER data: Can semaglutide cement its lead over Eli Lilly?
Novo Nordisk shares gained after STEER study showed Wegovy cut heart risks by 57% over tirzepatide. Find out why semaglutide may lead the GLP-1 race. Read More
EPAM Systems acquires Odysseus Data Services to bolster health data analytics capabilities
In a significant move within the digital transformation and health analytics sectors, EPAM Systems, Inc. (NYSE: EPAM) has announced its acquisition of Odysseus Data Services, ... Read More
Medtronic’s MiniMed 780G System sets new standards in diabetes management
Medtronic plc (NYSE: MDT), a global frontrunner in medical technology, has recently unveiled compelling new clinical and real-world evidence regarding the MiniMed 780G system, marking ... Read More